LncRNA AFAP1-AS1 is a prognostic biomarker and serves as oncogenic role in retinoblastoma

作者: Fengqin Hao , Yanan Mou , Laixia Zhang , Shuna Wang , Yang Yang

DOI: 10.1042/BSR20180384

关键词:

摘要: The actin filament-associated protein 1 antisense RNA (AFAP1-AS1) has been found to serve as an oncogenic long noncoding (lncRNA) in most types of human cancer. role AFAP1-AS1 retinoblastoma remains unknown. purpose the present study is explore clinical significance and biological function retinoblastoma. Levels expression were measured tissues cell lines. Loss-of-function was performed observe effects on proliferation, cycle, migration, invasion. In our results, elevated lines, associated with tumor size, choroidal invasion, optic nerve Moreover, high independent unfavorable prognostic factor patients. experiment vitro suggested down-regulation inhibited migration blocked cycle. conclusion, functions lncRNA

参考文章(36)
Zhaoyang Zeng, Hao Bo, Zhaojian Gong, Yu Lian, Xiayu Li, Xiaoling Li, Wenling Zhang, Hao Deng, Ming Zhou, Shuping Peng, Guiyuan Li, Wei Xiong, AFAP1-AS1, a long noncoding RNA upregulated in lung cancer and promotes invasion and metastasis Tumor Biology. ,vol. 37, pp. 729- 737 ,(2016) , 10.1007/S13277-015-3860-X
Hao Bo, Zhaojian Gong, Wenling Zhang, Xiayu Li, Yong Zeng, Qianjin Liao, Pan Chen, Lei Shi, Yu Lian, Yizhou Jing, Ke Tang, Zheng Li, Yanhong Zhou, Ming Zhou, Bo Xiang, Xiaoling Li, Jianbo Yang, Wei Xiong, Guiyuan Li, Zhaoyang Zeng, Upregulated long non-coding RNA AFAP1-AS1 expression is associated with progression and poor prognosis of nasopharyngeal carcinoma. Oncotarget. ,vol. 6, pp. 20404- 20418 ,(2015) , 10.18632/ONCOTARGET.4057
Jun Deng, Yujia Liang, Chunfeng Liu, Shengdong He, Songping Wang, The up-regulation of long non-coding RNA AFAP1-AS1 is associated with the poor prognosis of NSCLC patients Biomedicine & Pharmacotherapy. ,vol. 75, pp. 8- 11 ,(2015) , 10.1016/J.BIOPHA.2015.07.003
E Broaddus, A Topham, A D Singh, Incidence of retinoblastoma in the USA: 1975-2004 British Journal of Ophthalmology. ,vol. 93, pp. 21- 23 ,(2009) , 10.1136/BJO.2008.138750
Yibiao Ye, Jie Chen, Yu Zhou, Zhiqiang Fu, Quanbo Zhou, YingXue Wang, Wenchao Gao, ShangYou Zheng, Xiaohui Zhao, Tao Chen, Rufu Chen, High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarcinoma Journal of Translational Medicine. ,vol. 13, pp. 137- 137 ,(2015) , 10.1186/S12967-015-0490-4
Sören Müller, Susanne Raulefs, Philipp Bruns, Fabian Afonso-Grunz, Anne Plötner, Rolf Thermann, Carsten Jäger, Anna Melissa Schlitter, Bo Kong, Ivonne Regel, W Kurt Roth, Björn Rotter, Klaus Hoffmeier, Günter Kahl, Ina Koch, Fabian J Theis, Jörg Kleeff, Peter Winter, Christoph W Michalski, Erratum to: Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer. Molecular Cancer. ,vol. 14, pp. 94- 94 ,(2015) , 10.1186/S12943-015-0401-6
JIN-YAN ZHANG, MING-ZHE WENG, FANG-BIN SONG, YONG-GANG XU, QI LIU, JUN-YI WU, JUN QIN, TAO JIN, JUN-MING XU, Long noncoding RNA AFAP1-AS1 indicates a poor prognosis of hepatocellular carcinoma and promotes cell proliferation and invasion via upregulation of the RhoA/Rac2 signaling. International Journal of Oncology. ,vol. 48, pp. 1590- 1598 ,(2016) , 10.3892/IJO.2016.3385
Xu Lu, Chuang Zhou, Renfeng Li, Zhiwei Liang, Wenlong Zhai, Longshuan Zhao, Shuijun Zhang, Critical role for the long non-coding RNA AFAP1-AS1 in the proliferation and metastasis of hepatocellular carcinoma Tumor Biology. ,vol. 37, pp. 9699- 9707 ,(2016) , 10.1007/S13277-016-4858-8
Baoguo Zhou, Yuli Wang, Jinpeng Jiang, Hongpeng Jiang, Jianwei Song, Taotao Han, Juan Shi, Haiquan Qiao, None, The long noncoding RNA colon cancer-associated transcript-1/miR-490 axis regulates gastric cancer cell migration by targeting hnRNPA1 Iubmb Life. ,vol. 68, pp. 201- 210 ,(2016) , 10.1002/IUB.1474
Feng Wang, Hongbing Ni, Feng Sun, Min Li, Lin Chen, Overexpression of lncRNA AFAP1-AS1 correlates with poor prognosis and promotes tumorigenesis in colorectal cancer. Biomedicine & Pharmacotherapy. ,vol. 81, pp. 152- 159 ,(2016) , 10.1016/J.BIOPHA.2016.04.009